Results 241 to 250 of about 23,970 (278)
Some of the next articles are maybe not open access.
Boron-containing carbonic anhydrases inhibitors
Bioorganic ChemistryOver the last decades, the medicinal chemistry of boron-based compounds has been extensively explored, designing valuable small molecule drugs to tackle diseases and conditions, such as cancer, infections, inflammatory and neurological disorders.
Giovannuzzi, Simone +6 more
openaire +3 more sources
Polypharmacology of carbonic anhydrase inhibitors and activators
Expert Opinion on PharmacotherapyCarbonic anhydrases (CAs) are enzymes involved in many physiologic and pathological processes connected with a diversity of conditions. Many of their inhibitors are used clinically for the management of glaucoma, epilepsy, obesity, and cancer. Some of these compounds also show significant polypharmacological effects.
Alessandro, Bonardi, Claudiu T, Supuran
openaire +2 more sources
Recent advances in the medicinal chemistry of carbonic anhydrase inhibitors
European Journal of Medicinal Chemistry, 2021Shalini Jaswal, Vikramdeep Monga
exaly
Topical Carbonic Anhydrase Inhibitors
American Journal of Ophthalmology, 1989openaire +2 more sources
Current Medicinal Chemistry-Immunology, Endocrine & Metabolic Agents, 2001
Claudiu Supuran, Andrea Scozzafava
openaire +1 more source
Claudiu Supuran, Andrea Scozzafava
openaire +1 more source
Carbonic anhydrase inhibitors as emerging agents for the treatment and imaging of hypoxic tumors
Expert Opinion on Investigational Drugs, 2018Claudiu T Supuran
exaly
Carbonic anhydrase inhibitors: a review on the progress of patent literature (2011–2016)
Expert Opinion on Therapeutic Patents, 2016Carrie L Lomelino, Robert Mckenna
exaly